William H. Heyman, Vice Chairman of Travelers Companies (TRV), has been a consistent seller of the insurer’s stock over the past year, with Form 4 filings showing 71 total transactions and zero open-market purchases. The aggregate sell value reached $18.7 million, all in TRV, while his acquisition activity was limited to option exercises (code M) and equity awards (code A) that carried no cash outlay. The most recent cluster of trades, spanning November 2025 through April 2026, shows 13 open-market sales totaling roughly $5.4 million, paired with an equal number of option exercises that supplied the shares being liquidated.
The pattern is mechanical rather than directional: Heyman regularly exercises vested options at strike prices between $172,500 and $862,500 per transaction, then immediately sells the resulting shares in the open market. For example, on February 5, 2026, he exercised options worth $862,500 and sold $1.51 million of TRV stock; on February 23, he exercised $739,530 in options and sold $920,755. The largest single sale came on February 18, when $1.66 million in shares were withheld to cover tax obligations on restricted stock vesting—an automatic disposition, not a discretionary trade. Smaller sales of $290,000 to $311,000 occurred on a near-monthly cadence, suggesting a pre-arranged 10b5-1 plan or routine portfolio rebalancing rather than a reaction to company news.
Notably, Heyman has not made a single open-market purchase of TRV shares during the entire filing period, and his total acquired value from grants and exercises is zero in cash terms—the shares came solely from compensation. The sell bias is unambiguous, but it is driven by option expirations and tax withholding, not by a concentrated bet against the stock. His last reported trade was on April 28, 2026, when he sold $483,670 in two tranches after exercising options worth $294,288, leaving his net position in Travelers reduced but still substantial.
AI-assisted summary